XTNT — Xtant Medical Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $65.75m
- $93.83m
- $117.27m
- 33
- 65
- 36
- 41
Annual cashflow statement for Xtant Medical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.02 | -4.85 | -8.48 | 0.66 | -16.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 7.49 | 3.16 | 4.66 | -7.81 | 5.66 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.27 | 0.793 | -2.81 | -3.63 | -5.35 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.731 | 0.439 | -5.34 | -9.52 | -11.9 |
| Capital Expenditures | -1.54 | -2.12 | -1.76 | -1.46 | -4.11 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.241 | 0.225 | 0.205 | -23.3 | 0.383 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -1.3 | -1.89 | -1.56 | -24.8 | -3.73 |
| Financing Cash Flow Items | -1.06 | -0.337 | 0 | -0.261 | -0.829 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.861 | 17.5 | 9.02 | 19.7 | 16.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.9 | 16 | 2.12 | -14.6 | 0.298 |